Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan-Apr;21(1):100196.
doi: 10.1016/j.ijchp.2020.07.007. Epub 2020 Aug 31.

Prevalence of depression during the COVID-19 outbreak: A meta-analysis of community-based studies

Juan Bueno-Notivol  1 , Patricia Gracia-García  1   2 , Beatriz Olaya  3   2 , Isabel Lasheras  4 , Raúl López-Antón  2   5   6 , Javier Santabárbara  2   4   6
Affiliations

Prevalence of depression during the COVID-19 outbreak: A meta-analysis of community-based studies

Juan Bueno-Notivol et al. Int J Clin Health Psychol. 2021 Jan-Apr.

Abstract
in English, Spanish

Introduction: COVID-19 pandemic, declared on March 11, 2020, constitute an extraordinary health, social and economic global challenge. The impact on people's mental health is expected to be high. This paper sought to systematically review community-based studies on depression conducted during the COVID-19 and estimate the pooled prevalence of depression. Method: We searched for cross-sectional, community-based studies listed on PubMed or Web of Science from January 1, 2020 to May 8, 2020 that reported prevalence of depression. A random effect model was used to estimate the pooled proportion of depression. Results: A total of 12 studies were included in the meta-analysis, with prevalence rates of depression ranging from 7.45% to 48.30%. The pooled prevalence of depression was 25% (95% CI: 18% - 33%), with significant heterogeneity between studies (I 2 = 99.60%, p < .001). Conclusions: Compared with a global estimated prevalence of depression of 3.44% in 2017, our pooled prevalence of 25% appears to be 7 times higher, thus suggesting an important impact of the COVID-19 outbreak on people's mental health. Addressing mental health during and after this global health crisis should be placed into the international and national public health agenda to improve citizens' wellbeing.

Introducción: La pandemia de COVID-19, declarada el 11 de marzo de 2020, representa un reto global extraordinario a nivel sanitario, social y económico. Se espera un impacto alto en la salud mental de las personas. Este artículo tiene como objetivo realizar una revisión sistemática de estudios transversales basados en muestras comunitarias que proporcionaban la prevalencia de depresión durante la crisis del COVID-19. Método: Se realizó una búsqueda de estudios comunitarios publicados en Pubmed y Web of Science desde el 1 de enero del 2020 al 8 de mayo del 2020 y que informaron sobre la prevalencia de depresión. Se usó un modelo de efectos aleatorios para estimar la proporción agrupada de depresión. Resultados: Un total de 12 estudios fueron incluidos en el meta-análisis, con prevalencias de depresión que oscilaban entre 7,45% y 48,30%. La prevalencia agrupada de depresión fue de 25% (95% CI: 18%-33%), con heterogeneidad significativa entre estudios (I 2 = 99,60%, p < 0,001). Conclusiones: En comparación con una estimación global de depresión en 2017 del 3,44%, nuestra prevalencia agrupada del 25% es 7 veces mayor, sugiriendo un impacto importante del brote de COVID-19 en la salud mental de las personas. El abordaje de la salud mental durante y después de esta crisis global sanitaria debe ser parte de las agendas de salud pública nacionales e internacionales para mejorar el bienestar de los ciudadanos.

Keywords: COVID-19; Depression; community-based studies; meta-analysis.; prevalence.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of the study selection.
Figure 2
Figure 2
Forest plot for the prevalence of depression.
Figure 3
Figure 3
Funnel plot for the prevalence of depression.
See this image and copyright information in PMC

References

    1. Ahmed M.Z., Ahmed O., Aibao Z., Hanbin S., Siyu L., Ahmad A. Epidemic of COVID-19 in China and associated Psychological Problems. Asian Journal of Psychiatry. 2020;51 doi: 10.1016/j.ajp.2020.102092. - DOI - PMC - PubMed
    1. Asmundson, G.J.G., & Taylor, S. (2020). Coronaphobia: Fear and the 2019-nCoV outbreak. Journal of Anxiety Disorders, 70, Advance online publication. doi: 10.1016/j.janxdis.2020.102196. - PMC - PubMed
    1. Begg C.B., Mazumdar M. Operating Characteristics of a Rank Correlation Test for Publication Bias. Biometrics. 1994;50:1088–1101. doi: 10.2307/2533446. - DOI - PubMed
    1. Brailovskaia J., Margraf J. Predicting adaptive and maladaptive responses to the Coronavirus (COVID-19) outbreak: A prospective longitudinal study. International Journal of Clinical and Health Psychology. 2021;21:183–191. doi: 10.1016/j.ijchp.2020.06.002. - DOI - PMC - PubMed
    1. Brooks S.K., Webster R.K., Smith L.E., Woodland L., Wessely S., Greenberg N., Rubin G.J. The psychological impact of quarantine and how to reduce it: Rapid review of the evidence. Lancet (London, England) 2020;395:912–920. doi: 10.1016/S0140-6736(20)30460-8. - DOI - PMC - PubMed